Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its ...
This piece of information throws light on such foods and suggests healthier alternatives.
Stocktwits on MSN
Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels
Phase 2 data showed rapid increases in CD34+ stem cells, allowing same-day dosing and collection. ・Daratumumab-treated ...
Space-based computing offers easy access to solar power, but presents its own environmental challenges To hear Silicon Valley ...
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and Culture Biosciences, a bioprocess tools and software company, today announced a ...
GlobalData on MSN
Mirum to buy Bluejay for up to $820m in rare liver disease push
The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.
Deep vertical holes and re-entrant features challenge the best metrology methods.
Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for ...
Without this data center, there is a much higher probability of the need to increase our income tax, commissioners say.
Blackstone expected to launch a sale process for Sabre Industries, a manufacturer of steel utility poles and support ...
This past June and July, my family’s electricity bill jumped by more than 30% compared to last year. I know we’re not alone.
A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results